113 related articles for article (PubMed ID: 35672233)
1. Chemotherapy in patients with a solitary colorectal liver metastasis - A nationwide propensity score matched study.
Frühling P; Urdzik J; Isaksson B
Eur J Surg Oncol; 2022 Oct; 48(10):2188-2194. PubMed ID: 35672233
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
Solaini L; Gardini A; Passardi A; Mirarchi MT; D'Acapito F; La Barba G; Cucchi M; Casadei Gardini A; Frassineti GL; Cucchetti A; Ercolani G
Am Surg; 2019 May; 85(5):488-493. PubMed ID: 31126361
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
[TBL] [Abstract][Full Text] [Related]
4. Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer.
Xu D; Zhu HB; Wang YY; Jin KM; Yan XL; Li J; Wang K; Xing BC
Int J Colorectal Dis; 2022 Apr; 37(4):805-814. PubMed ID: 35188594
[TBL] [Abstract][Full Text] [Related]
5. Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.
Yoon YS; Kim CW; Lim SB; Yu CS; Kim SY; Kim TW; Kim MJ; Kim JC
J Surg Oncol; 2014 Mar; 109(3):239-44. PubMed ID: 24165972
[TBL] [Abstract][Full Text] [Related]
6. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
7. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
[TBL] [Abstract][Full Text] [Related]
8. Multicentre study of perioperative
Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
[TBL] [Abstract][Full Text] [Related]
9. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
Adam R; Bhangui P; Poston G; Mirza D; Nuzzo G; Barroso E; Ijzermans J; Hubert C; Ruers T; Capussotti L; Ouellet JF; Laurent C; Cugat E; Colombo PE; Milicevic M
Ann Surg; 2010 Nov; 252(5):774-87. PubMed ID: 21037433
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
11. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
12. Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score-matched analysis.
Imanishi M; Yamamoto Y; Hamano Y; Yamada T; Moriwaki T; Gosho M; Okumura T; Boku N; Kondo H; Hyodo I
Eur J Cancer; 2019 Jan; 106():69-77. PubMed ID: 30471650
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of simultaneous resection of colorectal primary tumor and liver metastasis after neoadjuvant therapy: A propensity score matching analysis.
Wu Y; Liu F; Song W; Liang F; Wang L; Xu Y
Am J Surg; 2019 Nov; 218(5):894-898. PubMed ID: 30268420
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.
Kawaguchi D; Hiroshima Y; Matsuo K; Endo I; Koda K; Tanaka K
Anticancer Res; 2016 Sep; 36(9):4725-30. PubMed ID: 27630319
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with colorectal liver metastases treated with and without preoperative chemotherapy: Nationwide propensity score-matched study.
de Graaff MR; Klaase JM; van Dam RM; Kuhlmann KFD; Kazemier G; Swijnenburg RJ; Elfrink AKE; Verhoef C; Mieog JS; van den Boezem PB; Gobardhan P; Rijken AM; Lips DJ; Leclercq WGK; Marsman HA; van Duijvendijk P; van der Hoeven JAB; Vermaas M; Dulk MD; Grünhagen DJ; Kok NFM;
Eur J Surg Oncol; 2023 Sep; 49(9):106932. PubMed ID: 37302900
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic combined resection of liver metastases and colorectal cancer: a multicenter, case-matched study using propensity scores.
van der Poel MJ; Tanis PJ; Marsman HA; Rijken AM; Gertsen EC; Ovaere S; Gerhards MF; Besselink MG; D'Hondt M; Gobardhan PD
Surg Endosc; 2019 Apr; 33(4):1124-1130. PubMed ID: 30069639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
